S.303 - Human Cloning Ban and Stem Cell Research Protection Act of 2003108th Congress (2003-2004)
|Sponsor:||Sen. Hatch, Orrin G. [R-UT] (Introduced 02/05/2003)|
|Committees:||Senate - Judiciary|
|Latest Action:||02/05/2003 Read twice and referred to the Committee on the Judiciary.|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Subject — Policy Area:
- View subjects
Summary: S.303 — 108th Congress (2003-2004)All Bill Information (Except Text)
Human Cloning Ban and Stem Cell Research Protection Act of 2003 - Amends the Federal criminal code to prohibit: (1) conducting or attempting to conduct human cloning; (2) shipping the product of nuclear transplantation for the purpose of human cloning in the United States or elsewhere; or (3) exporting to a foreign country an unfertilized blastocyst if such country does not prohibit human cloning.
Introduced in Senate (02/05/2003)
Requires the Comptroller General to report to the congressional judiciary committees on: (1) actions taken to enforce such prohibitions; (2) actions of State attorneys general to enforce similar State laws; (3) the Federal-State-local government coordination of enforcement actions; and (4) international laws relating to human cloning.
Amends the Public Health Service Act to require research involving nuclear transplantation to be conducted in accordance with applicable Federal standards for the protection of human subjects. Prohibits: (1) a somatic cell nucleus from being transplanted into a human oocyte (egg) that has undergone or will undergo fertilization; (2) an unfertilized blastocyst from being maintained after more than 14 days from its first cell division, not counting storage times at temperatures less than zero degrees centigrade; (3) an oocyte from being used in nuclear transplantation research unless donated voluntarily with the donor's informed consent; (4) an oocyte or unfertilized blastocyst from being acquired, received, or transferred for valuable consideration in interstate commerce; or (5) the conduct in a laboratory of nuclear transplantation in which human oocytes are subject to assisted reproductive technology treatments or procedures.